Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):330–337. doi: 10.1097/QAI.0000000000001503

Figure 2.

Figure 2

Example of summary table presented to study sites – percentage of plasma samples among participants in the active arm with dapivirine > 20 pg/mL and > 95 pg/mL